{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:09:52Z","timestamp":1778155792513,"version":"3.51.4"},"reference-count":59,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2002,4,15]]},"abstract":"<jats:p> PURPOSE: BRCA1 mutation carriers have a high risk of developing breast and ovarian cancer. Carriers may opt for prophylactic surgery and screening. Recent data suggesting that prophylactic oophorectomy reduces breast cancer risk have been incorporated in a decision analysis. <\/jats:p><jats:p> METHODS: A Markov model was developed to compare LE and QALE following four strategies: (1) prophylactic mastectomy and prophylactic oophorectomy (PMPO), (2) screening for breast cancer and prophylactic oophorectomy (BSPO), (3) prophylactic mastectomy and screening for ovarian cancer (PMOS), and (4) screening for breast and ovarian cancer (BSOS). The analysis was performed for a high (85% breast cancer, 63% ovarian cancer) and medium (56% breast cancer, 16% ovarian cancer) risk level. Utilities for the health states after prophylactic surgery were obtained from mutation carriers. Other model parameter values were obtained from the literature. Sensitivity analyses were performed. <\/jats:p><jats:p> RESULTS: When compared with BSOS, the average gain in LE for 30-year-old carriers in the high (medium) risk group was 11.7 (6.6) years for PMPO, 9.5 (5.3) years for BSPO, and 4.9 (4.4) years for PMOS. For 30-year-old carriers, BSPO had a QALE advantage when PO was performed before age 40. In the medium-risk group, there was a stronger advantage for BSPO when QALE was considered. <\/jats:p><jats:p> CONCLUSION: PMPO is the most effective strategy to prolong life. However, if patient preferences were taken into account, BSPO tends to be a better strategy in most women at medium risk or in young women at high risk when PO was performed before age 40. <\/jats:p>","DOI":"10.1200\/jco.2002.08.035","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T13:13:48Z","timestamp":1027775628000},"page":"2092-2100","source":"Crossref","is-referenced-by-count":79,"title":["Decision Analysis of Prophylactic Surgery or Screening for <i>BRCA1<\/i> Mutation Carriers: A More Prominent Role For Oophorectomy"],"prefix":"10.1200","volume":"20","author":[{"given":"Mari\u00eblle S.","family":"van Roosmalen","sequence":"first","affiliation":[{"name":"From the Joint Center for Radiation Oncology Arnhem-Nijmegen (RADIAN) and Department of Human Genetics and Hereditary Cancer Clinic, University Medical Center Nijmegen; Nijmegen Institute for Cognition and Information, University of Nijmegen; and Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia C.G.","family":"Verhoef","sequence":"additional","affiliation":[{"name":"From the Joint Center for Radiation Oncology Arnhem-Nijmegen (RADIAN) and Department of Human Genetics and Hereditary Cancer Clinic, University Medical Center Nijmegen; Nijmegen Institute for Cognition and Information, University of Nijmegen; and Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peep F.M.","family":"Stalmeier","sequence":"additional","affiliation":[{"name":"From the Joint Center for Radiation Oncology Arnhem-Nijmegen (RADIAN) and Department of Human Genetics and Hereditary Cancer Clinic, University Medical Center Nijmegen; Nijmegen Institute for Cognition and Information, University of Nijmegen; and Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[{"name":"From the Joint Center for Radiation Oncology Arnhem-Nijmegen (RADIAN) and Department of Human Genetics and Hereditary Cancer Clinic, University Medical Center Nijmegen; Nijmegen Institute for Cognition and Information, University of Nijmegen; and Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem A.J.","family":"van Daal","sequence":"additional","affiliation":[{"name":"From the Joint Center for Radiation Oncology Arnhem-Nijmegen (RADIAN) and Department of Human Genetics and Hereditary Cancer Clinic, University Medical Center Nijmegen; Nijmegen Institute for Cognition and Information, University of Nijmegen; and Department of Medical Psychology, Academic Medical Center, Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-107016","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954"},{"key":"R2-107016","unstructured":"Whittemore  AS,   Gong  G,   Itnyre  J:   Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer:  Results from three U.S. population-based case-control studies of ovarian cancer.   Am J Human Genet 60:  496,1997-504,"},{"key":"R3-107016","unstructured":"Ford  D,   Easton  DF,   Peto  J:   Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.  Am J Hum Genet 57:  1457,1995-1462,"},{"key":"R4-107016","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z"},{"key":"R5-107016","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320560305"},{"key":"R6-107016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705153362001"},{"key":"R7-107016","doi-asserted-by":"publisher","DOI":"10.1086\/301749"},{"key":"R8-107016","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540360065034"},{"key":"R9-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02347-3"},{"key":"R10-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.9.1980"},{"key":"R11-107016","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.17.1475"},{"key":"R13-107016","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(92)90215-K"},{"key":"R14-107016","unstructured":"Meijer  WJ,   van Lindert  ACM:     N Engl J Med 337:  788,1997  (letter)"},{"key":"R15-107016","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W"},{"key":"R16-107016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199109123251102"},{"key":"R17-107016","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7148.1858"},{"key":"R18-107016","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050096"},{"key":"R19-107016","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1611(200011\/12)9:6<496::AID-PON487>3.0.CO;2-Z"},{"key":"R20-107016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705153362022"},{"key":"R21-107016","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9801800402"},{"key":"R22-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.979"},{"key":"R23-107016","doi-asserted-by":"crossref","unstructured":"Grann  VR,   Whang  W,   Jacobson  JS,  et al:  Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2.  J Clin Oncol 17:  495,1999-500,","DOI":"10.1200\/JCO.1999.17.2.494"},{"key":"R24-107016","unstructured":"Grann  VR,   Jacobson  JS,   Whang  W,  et al:  Prevention with Tamoxifen or other hormones versus prophylactic surgery in BRCA1\/2-positive women:  A decision analysis.   Cancer J Sci Am 6:  13,2000-20,"},{"key":"R25-107016","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300409"},{"key":"R28-107016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400201"},{"key":"R29-107016","unstructured":"Hartmann  LC,   Schaid  D,   Sellers  T,  et al:  Bilateral prophylactic mastectomy (PM) in BRCA1\/2 mutation carriers.  Proc Am Assoc Cancer Res 41:  222,2000  (abstr)"},{"key":"R30-107016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107193450301"},{"key":"R31-107016","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J"},{"key":"R34-107016","unstructured":"Philips  KA:   Immnunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.  J Clin Oncol 18:  107s,2000-112s,"},{"key":"R35-107016","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5"},{"key":"R36-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)07065-7"},{"key":"R37-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.24.4053"},{"key":"R38-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00288-3"},{"key":"R39-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(00)00460-8"},{"key":"R40-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.924"},{"key":"R41-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.397"},{"key":"R42-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.5.1642"},{"key":"R43-107016","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.3.259"},{"key":"R44-107016","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006350518190"},{"key":"R45-107016","doi-asserted-by":"crossref","unstructured":"Robson  M:   Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.  J Clin Oncol 18:  113s,2000-118s,     (suppl 1)","DOI":"10.1002\/(SICI)1098-2388(200006)18:4<296::AID-SSU4>3.0.CO;2-4"},{"key":"R46-107016","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1341"},{"key":"R48-107016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611073351901"},{"key":"R49-107016","unstructured":"Fromm  GL,   Gershenson  D,   Silva  E:   Papillary serous carcinoma of the peritoneum.  Obstet Gynecol 75:  89,1990-95,"},{"key":"R50-107016","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F"},{"key":"R51-107016","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199404000-00003"},{"key":"R53-107016","unstructured":"Grann  VR,   Jacobson  JS,   Sundararajan  V,  et al:  The quality of life associated with prophylactic treatments for women with BRCA1\/2 mutations.  Cancer J Sci Am 5:  283,1999-292,"},{"key":"R54-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.9.1980"},{"key":"R55-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03258-X"},{"key":"R56-107016","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"R57-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85012-5"},{"key":"R58-107016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85011-3"},{"key":"R60-107016","unstructured":"Struewing  JP,   Watson  P,   Easton  DF,  et al:  Prophylactic oophorectomy in inherited breast\/ovarian cancer families.  J Natl Cancer Inst Monogr 17:  33,1995-35,"},{"key":"R63-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.11.3396"},{"key":"R64-107016","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520260071035"},{"key":"R65-107016","doi-asserted-by":"publisher","DOI":"10.1155\/1999\/805420"},{"key":"R66-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.924"},{"key":"R67-107016","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.14.1095"},{"key":"R68-107016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.15.3524"},{"key":"R69-107016","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.3.319"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/jco.2002.08.035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:57:19Z","timestamp":1653515839000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/jco.2002.08.035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,15]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,4,15]]}},"alternative-id":["10.1200\/jco.2002.08.035"],"URL":"https:\/\/doi.org\/10.1200\/jco.2002.08.035","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,15]]}}}